| Item Type | Name |
|
Concept
|
Myositis
|
|
Concept
|
Myositis, Inclusion Body
|
|
Academic Article
|
Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies.
|
|
Academic Article
|
The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.
|
|
Academic Article
|
Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci.
|
|
Academic Article
|
Update on myositis-specific and myositis-associated autoantibodies.
|
|
Academic Article
|
HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies.
|
|
Academic Article
|
Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies.
|
|
Academic Article
|
Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.
|
|
Academic Article
|
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.
|
|
Academic Article
|
Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
|
|
Academic Article
|
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis.
|
|
Academic Article
|
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
|
|
Academic Article
|
Autoantibodies in polymyositis.
|
|
Academic Article
|
Immunologic aspects of myositis.
|
|
Academic Article
|
Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease.
|
|
Academic Article
|
NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy.
|
|
Academic Article
|
Pulmonary fibrosis and myositis in a child with anti-Jo-1 antibody.
|
|
Academic Article
|
Immune manifestations of inflammatory muscle disease.
|
|
Academic Article
|
Coexistence of two antisynthetases in a patient with the antisynthetase syndrome.
|
|
Academic Article
|
Classification criteria for the idiopathic inflammatory myopathies.
|
|
Academic Article
|
Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.
|
|
Academic Article
|
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
|
|
Academic Article
|
Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures.
|
|
Academic Article
|
Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
|
|
Academic Article
|
The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.
|
|
Academic Article
|
Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.
|
|
Academic Article
|
Brief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.
|
|
Academic Article
|
Long-term outcomes in Juvenile Myositis patients.
|
|
Academic Article
|
Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease.
|
|
Academic Article
|
A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
|
|
Academic Article
|
Humoral immunity in polymyositis and dermatomyositis.
|
|
Academic Article
|
Antibody to threonyl-transfer RNA synthetase in myositis sera.
|
|
Academic Article
|
Antibodies to Mi-1 in SLE: relationship to other precipitins and reaction with bovine immunoglobulin.
|
|
Academic Article
|
Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes.
|
|
Academic Article
|
Analysis of the specificity of anti-PM-Scl autoantibodies.
|
|
Academic Article
|
A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children.
|
|
Academic Article
|
Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis.
|
|
Academic Article
|
Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis.
|
|
Academic Article
|
Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis.
|
|
Academic Article
|
Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
|
|
Academic Article
|
Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease.
|
|
Academic Article
|
Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies.
|
|
Academic Article
|
Polymyositis.
|
|
Academic Article
|
HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis.
|
|
Academic Article
|
Idiopathic inflammatory myopathy: autoantibody update.
|
|
Academic Article
|
Immune mechanisms in myositis.
|
|
Academic Article
|
Laboratory manifestations of polymyositis/dermatomyositis.
|
|
Academic Article
|
Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.
|
|
Academic Article
|
Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review.
|
|
Academic Article
|
Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity.
|
|
Academic Article
|
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
|
|
Academic Article
|
An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.
|
|
Academic Article
|
Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography.
|
|
Academic Article
|
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
|
|
Academic Article
|
Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.
|
|
Academic Article
|
Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops.
|
|
Academic Article
|
Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
|
|
Academic Article
|
Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
|
|
Academic Article
|
Myositis specific autoantibodies.
|
|
Academic Article
|
Autoantibodies and their significance in myositis.
|
|
Academic Article
|
The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
|
|
Academic Article
|
Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
|
|
Academic Article
|
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients.
|
|
Academic Article
|
Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase).
|
|
Academic Article
|
Diagnosis and treatment of polymyositis and dermatomyositis.
|
|
Academic Article
|
Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis.
|
|
Academic Article
|
C4 null genes in American whites and blacks with myositis.
|
|
Academic Article
|
Antibody to signal recognition particle in polymyositis.
|
|
Academic Article
|
The association between Mi-2 antibodies and dermatomyositis.
|
|
Academic Article
|
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy.
|
|
Academic Article
|
Humoral immunity in polymyositis/dermatomyositis.
|
|
Academic Article
|
Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.
|
|
Academic Article
|
Autoantibodies to glycyl-transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneity.
|
|
Academic Article
|
Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies.
|
|
Grant
|
AUTOANTIBODIES IN DERMATOMYOSITIS
|
|
Academic Article
|
Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis.
|
|
Academic Article
|
Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes.
|
|
Academic Article
|
Anti-Sp4 autoantibodies co-occur with anti-TIF1 and are associated with distinct clinical features and immunogenetic risk factors in juvenile myositis.
|
|
Academic Article
|
Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies.
|
|
Academic Article
|
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
|
|
Academic Article
|
Myositis-associated autoantibodies in juvenile myositis are associated with refractory disease and mortality.
|